We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

1 hedge funds and large institutions have $1 invested in Statera Biopharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TAM
1
Tucker Asset Management
Colorado
$1 – – –

STAB Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q4 2023, worth a combined $1.

Fund positioning in STAB was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Statera Biopharma, Inc. Common Stock (STAB) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $1 of Statera Biopharma, Inc. Common Stock stock for Q4 2023.
  • 0 funds opened new Statera Biopharma, Inc. Common Stock positions in Q4 2023 and 0 closed out.

Based on aggregated 13F filings for Q4 2023.